|
Tip |
Objava |
| 339 |
časopis |
Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D.
Stability of heroin hydrochloride in infusion devices and containers for intravenous administration.
Am J Hosp Pharm 1990 ; 47: 377-381. |
| 484 |
časopis |
Northcott M, Allsopp MA, Powell H, Sewell GJ.
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions.
J Clin Pharm Ther 1991 ; 16: 123-129. |
| 506 |
časopis |
Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P.
Diamorphine stability in aqueous solution for subcutaneous infusion.
J Pharm Pharmacol 1989 ; 41: 275-277. |
| 512 |
časopis |
Barnes AR, Nash S.
Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion.
Pharm World Sci 1995 ; 17: 87-92. |
| 779 |
časopis |
Collins AJ, Abethell JA, Holmes SG, Rain R.
Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration.
J Pharm Pharmacol 1986 ; 38: 51P. |
| 788 |
časopis |
Regnard CFB, Mannix K.
Subcutaneous drug compatibility in palliative care.
Lancet 1989 ; 2 (8670): 1044-1045. |
| 1230 |
časopis |
Regnard C, Pashley S, Westrope F.
Anti-emetic / diamorphine mixture compatibility in infusion pumps.
Br J Pharm Pract 1986 ; 8: 218-220. |
| 1232 |
časopis |
Beatson C, Taylor A.
A physical compatibility study of furosemide & flucloxacillin injections.
Br J Pharm Pract 1987 ; 9: 223-226, 236. |
| 1288 |
časopis |
Allwood MC, Brown PW, Lee M.
Stability of injections containing diamorphine and midazolam in plastic syringes.
Int J Pharm Pract 1994 ; 3: 57-59. |
| 1292 |
časopis |
Grassby PF, Roberts DE.
Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags.
Int J Pharm Pract 1995 ; 3: 174-177. |
| 1385 |
časopis |
Kirk B, Hain WR.
Diamorphine injection BP incompatibility.
Pharm J 1985 ; 235: 171. |
| 1388 |
časopis |
Page J, Hudson S.
Diamorphine hydrochloride compatibility with saline.
Pharm J 1982 ; 228: 238-239. |
| 1886 |
časopis |
Allwood MC.
The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes.
Palliative Med 1991 ; 5: 330-333. |
| 2051 |
časopis |
Sanchez del Aguila MJ, Jones MF, Vohra A.
Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability.
Br J Anaesth 2003 ; 90: 179-182. |
| 2307 |
časopis |
Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.
Epidural diamorphine and bupivacaine stability study.
Palliative Med 1995 ; 9, 4: 315-318. |
| 2308 |
časopis |
Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M.
Stability of premixed syringes of diamorphine and hyperbaric bupivacaine.
Int J Obstet Anesth 2005 ; 14, 4: 284-287. |
| 2404 |
časopis |
Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J.
The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes
Palliative Med 2000 ; 14: 205-208. |
| 3184 |
Traduction Laboratorij |
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
CP Pharmaceuticals 2005 |
| 3504 |
Traduction Laboratorij |
Parecoxib (Dynastat®) - Summary of Product Characteristics
Pfizer 2012 |
